Patent Assignment
Reel/Frame 061947/0320
Merger
Recorded: 2022-12-01
Pages: 6
Assignor
ABEXXA BIOLOGICS, INC.
Executed: 2021-12-15
Assignee
BOEHRINGER INGELHEIM PHARAMCEUTICALS, INC.
900 RIDGEBURY ROAD, P.O. BOX 368, RIDGEFIELD, CONNECTICUT, 06877
Covered Properties
(2)
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application:
18/000,486 →
Publication:
US 2024/0026007
Antibodies Targeting a Complex Comprising Non-Classical Hla-I and Neoantigen and Their Methods of Use
Application:
18/000,493 →
Publication:
US 2023/0303701
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 1, 2022
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 061947/0314 →
Assignment of Assignor's Interest
Dec 1, 2022
From: BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.
To: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Reel/Frame 061947/0344 →
Assignment of Assignor's Interest
Dec 1, 2022
From: WEIDANZ, JON; UPCHURCH-ANGE, KATHERINE
To: ABEXXA BIOLOGICS, INC.
Reel/Frame 062039/0081 →